Therapy preferences in melanoma treatment —Willingness to pay and preference of quality versus length of life of patients, physicians, healthy individuals and physicians with oncological disease

ConclusionThe valuation of the different treatment options differs in the four study groups with affected people valuing life prolongation much more. The individual value of cancer therapies is high, but differs from the societal standpoint.

Source: Cancer Medicine - July 9, 2020 Category: Cancer & Oncology Authors: Julia Weiss, Michael Constantin Kirchberger, Lucie Heinzerling Tags: ORIGINAL RESEARCH Source Type: research